Global Newcastle Disease Vaccine Supply, Demand and Key Producers, 2026-2032
The global Newcastle Disease Vaccine market size is expected to reach $ 443 million by 2032, rising at a market growth of 3.2% CAGR during the forecast period (2026-2032).
Newcastle Disease Vaccine is a critical biological product used to prevent Newcastle disease, a highly contagious viral infection affecting poultry such as chickens and ducks. The vaccine works by stimulating the immune system to produce specific antibodies and cellular immune responses against the Newcastle disease virus (NDV), thereby reducing infection rates, mortality, and viral transmission. Depending on production technology and immunological characteristics, it can be categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each suited for different farming systems and immunization programs. With the ongoing industrialization and intensification of modern poultry farming, Newcastle disease vaccines have become an essential tool for ensuring biosecurity and controlling major infectious diseases, holding a significant position in the global animal vaccine market.In 2025, global Newcastle Disease Vaccine production reached approximately 138.29 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry meat and egg consumption and the expansion of large-scale farming operations, demand for Newcastle disease vaccines remains strong. Governments worldwide are strengthening animal disease prevention systems and incorporating vaccination into mandatory or recommended programs, significantly increasing market penetration. Meanwhile, large-scale farming enterprises are placing greater emphasis on biosecurity, transforming vaccines from a cost factor into a critical risk management tool. According to corporate reports and industry practices, vaccine technologies are evolving toward higher efficacy, improved safety, and multivalent formulations, enhancing application scope and product value.Despite strong growth, the industry faces several challenges. Vaccine production requires stringent biosafety and quality control standards, leading to complex processes and higher operational costs. Variations in viral strains across regions demand continuous technological upgrades to maintain efficacy. In addition, price competition and product homogenization in certain markets put pressure on profit margins. Limitations in cold chain logistics and uneven vaccination practices at the grassroots level may also affect overall disease control outcomes.Downstream demand is shifting from fragmented farming to large-scale and standardized operations, driving more systematic and regulated vaccine usage. Large poultry producers are establishing comprehensive immunization programs, demanding higher consistency and reliability from vaccine products. At the same time, expansion of poultry farming in emerging markets is creating new demand opportunities. Increasing awareness of food safety and animal welfare is also driving demand for vaccines with higher safety profiles and fewer side effects, promoting industry premiumization.Upstream components mainly include viral seed strains, culture media, embryonated eggs, and adjuvants. High-quality seed strains and stable biological cultivation systems are fundamental to vaccine development and production, directly impacting efficacy and safety. With advances in biotechnology, upstream processes are becoming more standardized and scalable, although key materials still involve significant technical barriers. Supply chain stability and quality consistency are increasingly critical competitive factors in the industry.
This report studies the global Newcastle Disease Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Newcastle Disease Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newcastle Disease Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Newcastle Disease Vaccine total production and demand, 2021-2032, (M Doses)
Global Newcastle Disease Vaccine total production value, 2021-2032, (USD Million)
Global Newcastle Disease Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)
Global Newcastle Disease Vaccine consumption by region & country, CAGR, 2021-2032 & (M Doses)
U.S. VS China: Newcastle Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Newcastle Disease Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
This report profiles key players in the global Newcastle Disease Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, CEVA, CAHIC, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, Elanco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newcastle Disease Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Newcastle Disease Vaccine Market, By Region:
1. How big is the global Newcastle Disease Vaccine market?
2. What is the demand of the global Newcastle Disease Vaccine market?
3. What is the year over year growth of the global Newcastle Disease Vaccine market?
4. What is the production and production value of the global Newcastle Disease Vaccine market?
5. Who are the key producers in the global Newcastle Disease Vaccine market?
6. What are the growth factors driving the market demand?
Newcastle Disease Vaccine is a critical biological product used to prevent Newcastle disease, a highly contagious viral infection affecting poultry such as chickens and ducks. The vaccine works by stimulating the immune system to produce specific antibodies and cellular immune responses against the Newcastle disease virus (NDV), thereby reducing infection rates, mortality, and viral transmission. Depending on production technology and immunological characteristics, it can be categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each suited for different farming systems and immunization programs. With the ongoing industrialization and intensification of modern poultry farming, Newcastle disease vaccines have become an essential tool for ensuring biosecurity and controlling major infectious diseases, holding a significant position in the global animal vaccine market.In 2025, global Newcastle Disease Vaccine production reached approximately 138.29 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry meat and egg consumption and the expansion of large-scale farming operations, demand for Newcastle disease vaccines remains strong. Governments worldwide are strengthening animal disease prevention systems and incorporating vaccination into mandatory or recommended programs, significantly increasing market penetration. Meanwhile, large-scale farming enterprises are placing greater emphasis on biosecurity, transforming vaccines from a cost factor into a critical risk management tool. According to corporate reports and industry practices, vaccine technologies are evolving toward higher efficacy, improved safety, and multivalent formulations, enhancing application scope and product value.Despite strong growth, the industry faces several challenges. Vaccine production requires stringent biosafety and quality control standards, leading to complex processes and higher operational costs. Variations in viral strains across regions demand continuous technological upgrades to maintain efficacy. In addition, price competition and product homogenization in certain markets put pressure on profit margins. Limitations in cold chain logistics and uneven vaccination practices at the grassroots level may also affect overall disease control outcomes.Downstream demand is shifting from fragmented farming to large-scale and standardized operations, driving more systematic and regulated vaccine usage. Large poultry producers are establishing comprehensive immunization programs, demanding higher consistency and reliability from vaccine products. At the same time, expansion of poultry farming in emerging markets is creating new demand opportunities. Increasing awareness of food safety and animal welfare is also driving demand for vaccines with higher safety profiles and fewer side effects, promoting industry premiumization.Upstream components mainly include viral seed strains, culture media, embryonated eggs, and adjuvants. High-quality seed strains and stable biological cultivation systems are fundamental to vaccine development and production, directly impacting efficacy and safety. With advances in biotechnology, upstream processes are becoming more standardized and scalable, although key materials still involve significant technical barriers. Supply chain stability and quality consistency are increasingly critical competitive factors in the industry.
This report studies the global Newcastle Disease Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Newcastle Disease Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newcastle Disease Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Newcastle Disease Vaccine total production and demand, 2021-2032, (M Doses)
Global Newcastle Disease Vaccine total production value, 2021-2032, (USD Million)
Global Newcastle Disease Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)
Global Newcastle Disease Vaccine consumption by region & country, CAGR, 2021-2032 & (M Doses)
U.S. VS China: Newcastle Disease Vaccine domestic production, consumption, key domestic manufacturers and share
Global Newcastle Disease Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
Global Newcastle Disease Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
This report profiles key players in the global Newcastle Disease Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, CEVA, CAHIC, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN, Zoetis, Elanco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newcastle Disease Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Newcastle Disease Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Live Vaccines
- Killed Vaccines
- Spray Method
- Drinking Water
- Injection Method
- Large Farms
- Small Farms
- Government Use
- Chicken
- Duck & Goose
- Other
- Boehringer Ingelheim
- CEVA
- CAHIC
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- Elanco
- FATRO
- CAVAC
- Vaksindo
- Virbac
- Hester Biosciences
1. How big is the global Newcastle Disease Vaccine market?
2. What is the demand of the global Newcastle Disease Vaccine market?
3. What is the year over year growth of the global Newcastle Disease Vaccine market?
4. What is the production and production value of the global Newcastle Disease Vaccine market?
5. Who are the key producers in the global Newcastle Disease Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Newcastle Disease Vaccine Introduction
1.2 World Newcastle Disease Vaccine Supply & Forecast
1.2.1 World Newcastle Disease Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Newcastle Disease Vaccine Production (2021-2032)
1.2.3 World Newcastle Disease Vaccine Pricing Trends (2021-2032)
1.3 World Newcastle Disease Vaccine Production by Region (Based on Production Site)
1.3.1 World Newcastle Disease Vaccine Production Value by Region (2021-2032)
1.3.2 World Newcastle Disease Vaccine Production by Region (2021-2032)
1.3.3 World Newcastle Disease Vaccine Average Price by Region (2021-2032)
1.3.4 North America Newcastle Disease Vaccine Production (2021-2032)
1.3.5 Europe Newcastle Disease Vaccine Production (2021-2032)
1.3.6 Southeast Asia Newcastle Disease Vaccine Production (2021-2032)
1.3.7 Japan Newcastle Disease Vaccine Production (2021-2032)
1.3.8 China Newcastle Disease Vaccine Production (2021-2032)
1.3.9 South Korea Newcastle Disease Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Newcastle Disease Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Newcastle Disease Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Newcastle Disease Vaccine Demand (2021-2032)
2.2 World Newcastle Disease Vaccine Consumption by Region
2.2.1 World Newcastle Disease Vaccine Consumption by Region (2021-2026)
2.2.2 World Newcastle Disease Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Newcastle Disease Vaccine Consumption (2021-2032)
2.4 China Newcastle Disease Vaccine Consumption (2021-2032)
2.5 Europe Newcastle Disease Vaccine Consumption (2021-2032)
2.6 Japan Newcastle Disease Vaccine Consumption (2021-2032)
2.7 South Korea Newcastle Disease Vaccine Consumption (2021-2032)
2.8 ASEAN Newcastle Disease Vaccine Consumption (2021-2032)
2.9 India Newcastle Disease Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Newcastle Disease Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Newcastle Disease Vaccine Production by Manufacturer (2021-2026)
3.3 World Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026)
3.4 Newcastle Disease Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Newcastle Disease Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Newcastle Disease Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Newcastle Disease Vaccine in 2025
3.6 Newcastle Disease Vaccine Market: Overall Company Footprint Analysis
3.6.1 Newcastle Disease Vaccine Market: Region Footprint
3.6.2 Newcastle Disease Vaccine Market: Company Product Type Footprint
3.6.3 Newcastle Disease Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Newcastle Disease Vaccine Production Value Comparison
4.1.1 United States VS China: Newcastle Disease Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Newcastle Disease Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Newcastle Disease Vaccine Production Comparison
4.2.1 United States VS China: Newcastle Disease Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Newcastle Disease Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Newcastle Disease Vaccine Consumption Comparison
4.3.1 United States VS China: Newcastle Disease Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Newcastle Disease Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Newcastle Disease Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Newcastle Disease Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Newcastle Disease Vaccine Production (2021-2026)
4.5 China Based Newcastle Disease Vaccine Manufacturers and Market Share
4.5.1 China Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Newcastle Disease Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Newcastle Disease Vaccine Production (2021-2026)
4.6 Rest of World Based Newcastle Disease Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Newcastle Disease Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Newcastle Disease Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Live Vaccines
5.2.2 Killed Vaccines
5.3 Market Segment by Type
5.3.1 World Newcastle Disease Vaccine Production by Type (2021-2032)
5.3.2 World Newcastle Disease Vaccine Production Value by Type (2021-2032)
5.3.3 World Newcastle Disease Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION
6.1 World Newcastle Disease Vaccine Market Size Overview by Administration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration
6.2.1 Spray Method
6.2.2 Drinking Water
6.2.3 Injection Method
6.3 Market Segment by Administration
6.3.1 World Newcastle Disease Vaccine Production by Administration (2021-2032)
6.3.2 World Newcastle Disease Vaccine Production Value by Administration (2021-2032)
6.3.3 World Newcastle Disease Vaccine Average Price by Administration (2021-2032)
7 MARKET ANALYSIS BY END USER
7.1 World Newcastle Disease Vaccine Market Size Overview by End User: 2021 VS 2025 VS 2032
7.2 Segment Introduction by End User
7.2.1 Large Farms
7.2.2 Small Farms
7.2.3 Government Use
7.3 Market Segment by End User
7.3.1 World Newcastle Disease Vaccine Production by End User (2021-2032)
7.3.2 World Newcastle Disease Vaccine Production Value by End User (2021-2032)
7.3.3 World Newcastle Disease Vaccine Average Price by End User (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Newcastle Disease Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Chicken
8.2.2 Duck & Goose
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Newcastle Disease Vaccine Production by Application (2021-2032)
8.3.2 World Newcastle Disease Vaccine Production Value by Application (2021-2032)
8.3.3 World Newcastle Disease Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Details
9.1.2 Boehringer Ingelheim Major Business
9.1.3 Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
9.1.4 Boehringer Ingelheim Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Boehringer Ingelheim Recent Developments/Updates
9.1.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
9.2 CEVA
9.2.1 CEVA Details
9.2.2 CEVA Major Business
9.2.3 CEVA Newcastle Disease Vaccine Product and Services
9.2.4 CEVA Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 CEVA Recent Developments/Updates
9.2.6 CEVA Competitive Strengths & Weaknesses
9.3 CAHIC
9.3.1 CAHIC Details
9.3.2 CAHIC Major Business
9.3.3 CAHIC Newcastle Disease Vaccine Product and Services
9.3.4 CAHIC Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 CAHIC Recent Developments/Updates
9.3.6 CAHIC Competitive Strengths & Weaknesses
9.4 Ringpu Biology
9.4.1 Ringpu Biology Details
9.4.2 Ringpu Biology Major Business
9.4.3 Ringpu Biology Newcastle Disease Vaccine Product and Services
9.4.4 Ringpu Biology Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Ringpu Biology Recent Developments/Updates
9.4.6 Ringpu Biology Competitive Strengths & Weaknesses
9.5 Yebio
9.5.1 Yebio Details
9.5.2 Yebio Major Business
9.5.3 Yebio Newcastle Disease Vaccine Product and Services
9.5.4 Yebio Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Yebio Recent Developments/Updates
9.5.6 Yebio Competitive Strengths & Weaknesses
9.6 Harbin Veterinary Research Institute
9.6.1 Harbin Veterinary Research Institute Details
9.6.2 Harbin Veterinary Research Institute Major Business
9.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
9.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
9.6.6 Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
9.7 Merck Animal Health
9.7.1 Merck Animal Health Details
9.7.2 Merck Animal Health Major Business
9.7.3 Merck Animal Health Newcastle Disease Vaccine Product and Services
9.7.4 Merck Animal Health Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Merck Animal Health Recent Developments/Updates
9.7.6 Merck Animal Health Competitive Strengths & Weaknesses
9.8 DHN
9.8.1 DHN Details
9.8.2 DHN Major Business
9.8.3 DHN Newcastle Disease Vaccine Product and Services
9.8.4 DHN Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 DHN Recent Developments/Updates
9.8.6 DHN Competitive Strengths & Weaknesses
9.9 Zoetis
9.9.1 Zoetis Details
9.9.2 Zoetis Major Business
9.9.3 Zoetis Newcastle Disease Vaccine Product and Services
9.9.4 Zoetis Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Zoetis Recent Developments/Updates
9.9.6 Zoetis Competitive Strengths & Weaknesses
9.10 Elanco
9.10.1 Elanco Details
9.10.2 Elanco Major Business
9.10.3 Elanco Newcastle Disease Vaccine Product and Services
9.10.4 Elanco Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Elanco Recent Developments/Updates
9.10.6 Elanco Competitive Strengths & Weaknesses
9.11 FATRO
9.11.1 FATRO Details
9.11.2 FATRO Major Business
9.11.3 FATRO Newcastle Disease Vaccine Product and Services
9.11.4 FATRO Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 FATRO Recent Developments/Updates
9.11.6 FATRO Competitive Strengths & Weaknesses
9.12 CAVAC
9.12.1 CAVAC Details
9.12.2 CAVAC Major Business
9.12.3 CAVAC Newcastle Disease Vaccine Product and Services
9.12.4 CAVAC Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 CAVAC Recent Developments/Updates
9.12.6 CAVAC Competitive Strengths & Weaknesses
9.13 Vaksindo
9.13.1 Vaksindo Details
9.13.2 Vaksindo Major Business
9.13.3 Vaksindo Newcastle Disease Vaccine Product and Services
9.13.4 Vaksindo Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Vaksindo Recent Developments/Updates
9.13.6 Vaksindo Competitive Strengths & Weaknesses
9.14 Virbac
9.14.1 Virbac Details
9.14.2 Virbac Major Business
9.14.3 Virbac Newcastle Disease Vaccine Product and Services
9.14.4 Virbac Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Virbac Recent Developments/Updates
9.14.6 Virbac Competitive Strengths & Weaknesses
9.15 Hester Biosciences
9.15.1 Hester Biosciences Details
9.15.2 Hester Biosciences Major Business
9.15.3 Hester Biosciences Newcastle Disease Vaccine Product and Services
9.15.4 Hester Biosciences Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Hester Biosciences Recent Developments/Updates
9.15.6 Hester Biosciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Newcastle Disease Vaccine Industry Chain
10.2 Newcastle Disease Vaccine Upstream Analysis
10.2.1 Newcastle Disease Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Newcastle Disease Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Newcastle Disease Vaccine Production Mode
10.6 Newcastle Disease Vaccine Procurement Model
10.7 Newcastle Disease Vaccine Industry Sales Model and Sales Channels
10.7.1 Newcastle Disease Vaccine Sales Model
10.7.2 Newcastle Disease Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Newcastle Disease Vaccine Introduction
1.2 World Newcastle Disease Vaccine Supply & Forecast
1.2.1 World Newcastle Disease Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Newcastle Disease Vaccine Production (2021-2032)
1.2.3 World Newcastle Disease Vaccine Pricing Trends (2021-2032)
1.3 World Newcastle Disease Vaccine Production by Region (Based on Production Site)
1.3.1 World Newcastle Disease Vaccine Production Value by Region (2021-2032)
1.3.2 World Newcastle Disease Vaccine Production by Region (2021-2032)
1.3.3 World Newcastle Disease Vaccine Average Price by Region (2021-2032)
1.3.4 North America Newcastle Disease Vaccine Production (2021-2032)
1.3.5 Europe Newcastle Disease Vaccine Production (2021-2032)
1.3.6 Southeast Asia Newcastle Disease Vaccine Production (2021-2032)
1.3.7 Japan Newcastle Disease Vaccine Production (2021-2032)
1.3.8 China Newcastle Disease Vaccine Production (2021-2032)
1.3.9 South Korea Newcastle Disease Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Newcastle Disease Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Newcastle Disease Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Newcastle Disease Vaccine Demand (2021-2032)
2.2 World Newcastle Disease Vaccine Consumption by Region
2.2.1 World Newcastle Disease Vaccine Consumption by Region (2021-2026)
2.2.2 World Newcastle Disease Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Newcastle Disease Vaccine Consumption (2021-2032)
2.4 China Newcastle Disease Vaccine Consumption (2021-2032)
2.5 Europe Newcastle Disease Vaccine Consumption (2021-2032)
2.6 Japan Newcastle Disease Vaccine Consumption (2021-2032)
2.7 South Korea Newcastle Disease Vaccine Consumption (2021-2032)
2.8 ASEAN Newcastle Disease Vaccine Consumption (2021-2032)
2.9 India Newcastle Disease Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Newcastle Disease Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Newcastle Disease Vaccine Production by Manufacturer (2021-2026)
3.3 World Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026)
3.4 Newcastle Disease Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Newcastle Disease Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Newcastle Disease Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Newcastle Disease Vaccine in 2025
3.6 Newcastle Disease Vaccine Market: Overall Company Footprint Analysis
3.6.1 Newcastle Disease Vaccine Market: Region Footprint
3.6.2 Newcastle Disease Vaccine Market: Company Product Type Footprint
3.6.3 Newcastle Disease Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Newcastle Disease Vaccine Production Value Comparison
4.1.1 United States VS China: Newcastle Disease Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Newcastle Disease Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Newcastle Disease Vaccine Production Comparison
4.2.1 United States VS China: Newcastle Disease Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Newcastle Disease Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Newcastle Disease Vaccine Consumption Comparison
4.3.1 United States VS China: Newcastle Disease Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Newcastle Disease Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Newcastle Disease Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Newcastle Disease Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Newcastle Disease Vaccine Production (2021-2026)
4.5 China Based Newcastle Disease Vaccine Manufacturers and Market Share
4.5.1 China Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Newcastle Disease Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Newcastle Disease Vaccine Production (2021-2026)
4.6 Rest of World Based Newcastle Disease Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Newcastle Disease Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Newcastle Disease Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Live Vaccines
5.2.2 Killed Vaccines
5.3 Market Segment by Type
5.3.1 World Newcastle Disease Vaccine Production by Type (2021-2032)
5.3.2 World Newcastle Disease Vaccine Production Value by Type (2021-2032)
5.3.3 World Newcastle Disease Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ADMINISTRATION
6.1 World Newcastle Disease Vaccine Market Size Overview by Administration: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Administration
6.2.1 Spray Method
6.2.2 Drinking Water
6.2.3 Injection Method
6.3 Market Segment by Administration
6.3.1 World Newcastle Disease Vaccine Production by Administration (2021-2032)
6.3.2 World Newcastle Disease Vaccine Production Value by Administration (2021-2032)
6.3.3 World Newcastle Disease Vaccine Average Price by Administration (2021-2032)
7 MARKET ANALYSIS BY END USER
7.1 World Newcastle Disease Vaccine Market Size Overview by End User: 2021 VS 2025 VS 2032
7.2 Segment Introduction by End User
7.2.1 Large Farms
7.2.2 Small Farms
7.2.3 Government Use
7.3 Market Segment by End User
7.3.1 World Newcastle Disease Vaccine Production by End User (2021-2032)
7.3.2 World Newcastle Disease Vaccine Production Value by End User (2021-2032)
7.3.3 World Newcastle Disease Vaccine Average Price by End User (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Newcastle Disease Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Chicken
8.2.2 Duck & Goose
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Newcastle Disease Vaccine Production by Application (2021-2032)
8.3.2 World Newcastle Disease Vaccine Production Value by Application (2021-2032)
8.3.3 World Newcastle Disease Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Details
9.1.2 Boehringer Ingelheim Major Business
9.1.3 Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
9.1.4 Boehringer Ingelheim Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Boehringer Ingelheim Recent Developments/Updates
9.1.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
9.2 CEVA
9.2.1 CEVA Details
9.2.2 CEVA Major Business
9.2.3 CEVA Newcastle Disease Vaccine Product and Services
9.2.4 CEVA Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 CEVA Recent Developments/Updates
9.2.6 CEVA Competitive Strengths & Weaknesses
9.3 CAHIC
9.3.1 CAHIC Details
9.3.2 CAHIC Major Business
9.3.3 CAHIC Newcastle Disease Vaccine Product and Services
9.3.4 CAHIC Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 CAHIC Recent Developments/Updates
9.3.6 CAHIC Competitive Strengths & Weaknesses
9.4 Ringpu Biology
9.4.1 Ringpu Biology Details
9.4.2 Ringpu Biology Major Business
9.4.3 Ringpu Biology Newcastle Disease Vaccine Product and Services
9.4.4 Ringpu Biology Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Ringpu Biology Recent Developments/Updates
9.4.6 Ringpu Biology Competitive Strengths & Weaknesses
9.5 Yebio
9.5.1 Yebio Details
9.5.2 Yebio Major Business
9.5.3 Yebio Newcastle Disease Vaccine Product and Services
9.5.4 Yebio Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Yebio Recent Developments/Updates
9.5.6 Yebio Competitive Strengths & Weaknesses
9.6 Harbin Veterinary Research Institute
9.6.1 Harbin Veterinary Research Institute Details
9.6.2 Harbin Veterinary Research Institute Major Business
9.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
9.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Harbin Veterinary Research Institute Recent Developments/Updates
9.6.6 Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
9.7 Merck Animal Health
9.7.1 Merck Animal Health Details
9.7.2 Merck Animal Health Major Business
9.7.3 Merck Animal Health Newcastle Disease Vaccine Product and Services
9.7.4 Merck Animal Health Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Merck Animal Health Recent Developments/Updates
9.7.6 Merck Animal Health Competitive Strengths & Weaknesses
9.8 DHN
9.8.1 DHN Details
9.8.2 DHN Major Business
9.8.3 DHN Newcastle Disease Vaccine Product and Services
9.8.4 DHN Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 DHN Recent Developments/Updates
9.8.6 DHN Competitive Strengths & Weaknesses
9.9 Zoetis
9.9.1 Zoetis Details
9.9.2 Zoetis Major Business
9.9.3 Zoetis Newcastle Disease Vaccine Product and Services
9.9.4 Zoetis Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Zoetis Recent Developments/Updates
9.9.6 Zoetis Competitive Strengths & Weaknesses
9.10 Elanco
9.10.1 Elanco Details
9.10.2 Elanco Major Business
9.10.3 Elanco Newcastle Disease Vaccine Product and Services
9.10.4 Elanco Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Elanco Recent Developments/Updates
9.10.6 Elanco Competitive Strengths & Weaknesses
9.11 FATRO
9.11.1 FATRO Details
9.11.2 FATRO Major Business
9.11.3 FATRO Newcastle Disease Vaccine Product and Services
9.11.4 FATRO Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 FATRO Recent Developments/Updates
9.11.6 FATRO Competitive Strengths & Weaknesses
9.12 CAVAC
9.12.1 CAVAC Details
9.12.2 CAVAC Major Business
9.12.3 CAVAC Newcastle Disease Vaccine Product and Services
9.12.4 CAVAC Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 CAVAC Recent Developments/Updates
9.12.6 CAVAC Competitive Strengths & Weaknesses
9.13 Vaksindo
9.13.1 Vaksindo Details
9.13.2 Vaksindo Major Business
9.13.3 Vaksindo Newcastle Disease Vaccine Product and Services
9.13.4 Vaksindo Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Vaksindo Recent Developments/Updates
9.13.6 Vaksindo Competitive Strengths & Weaknesses
9.14 Virbac
9.14.1 Virbac Details
9.14.2 Virbac Major Business
9.14.3 Virbac Newcastle Disease Vaccine Product and Services
9.14.4 Virbac Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Virbac Recent Developments/Updates
9.14.6 Virbac Competitive Strengths & Weaknesses
9.15 Hester Biosciences
9.15.1 Hester Biosciences Details
9.15.2 Hester Biosciences Major Business
9.15.3 Hester Biosciences Newcastle Disease Vaccine Product and Services
9.15.4 Hester Biosciences Newcastle Disease Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Hester Biosciences Recent Developments/Updates
9.15.6 Hester Biosciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Newcastle Disease Vaccine Industry Chain
10.2 Newcastle Disease Vaccine Upstream Analysis
10.2.1 Newcastle Disease Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Newcastle Disease Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Newcastle Disease Vaccine Production Mode
10.6 Newcastle Disease Vaccine Procurement Model
10.7 Newcastle Disease Vaccine Industry Sales Model and Sales Channels
10.7.1 Newcastle Disease Vaccine Sales Model
10.7.2 Newcastle Disease Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Newcastle Disease Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Newcastle Disease Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Newcastle Disease Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Newcastle Disease Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Newcastle Disease Vaccine Production by Region (2021-2026) & (M Doses)
Table 7. World Newcastle Disease Vaccine Production by Region (2027-2032) & (M Doses)
Table 8. World Newcastle Disease Vaccine Production Market Share by Region (2021-2026)
Table 9. World Newcastle Disease Vaccine Production Market Share by Region (2027-2032)
Table 10. World Newcastle Disease Vaccine Average Price by Region (2021-2026) & (USD/K Doses)
Table 11. World Newcastle Disease Vaccine Average Price by Region (2027-2032) & (USD/K Doses)
Table 12. Newcastle Disease Vaccine Major Market Trends
Table 13. World Newcastle Disease Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Doses)
Table 14. World Newcastle Disease Vaccine Consumption by Region (2021-2026) & (M Doses)
Table 15. World Newcastle Disease Vaccine Consumption Forecast by Region (2027-2032) & (M Doses)
Table 16. World Newcastle Disease Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 18. World Newcastle Disease Vaccine Production by Manufacturer (2021-2026) & (M Doses)
Table 19. Production Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 20. World Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 21. Global Newcastle Disease Vaccine Company Evaluation Quadrant
Table 22. World Newcastle Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Newcastle Disease Vaccine Production Site of Key Manufacturer
Table 24. Newcastle Disease Vaccine Market: Company Product Type Footprint
Table 25. Newcastle Disease Vaccine Market: Company Product Application Footprint
Table 26. Newcastle Disease Vaccine Competitive Factors
Table 27. Newcastle Disease Vaccine New Entrant and Capacity Expansion Plans
Table 28. Newcastle Disease Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Newcastle Disease Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Newcastle Disease Vaccine Production Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 31. United States VS China Newcastle Disease Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 32. United States Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Newcastle Disease Vaccine Production (2021-2026) & (M Doses)
Table 36. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 37. China Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 41. China Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 46. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 47. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Newcastle Disease Vaccine Production by Type (2021-2026) & (M Doses)
Table 49. World Newcastle Disease Vaccine Production by Type (2027-2032) & (M Doses)
Table 50. World Newcastle Disease Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Newcastle Disease Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Newcastle Disease Vaccine Average Price by Type (2021-2026) & (USD/K Doses)
Table 53. World Newcastle Disease Vaccine Average Price by Type (2027-2032) & (USD/K Doses)
Table 54. World Newcastle Disease Vaccine Production Value by Administration, (USD Million), 2021 & 2025 & 2032
Table 55. World Newcastle Disease Vaccine Production by Administration (2021-2026) & (M Doses)
Table 56. World Newcastle Disease Vaccine Production by Administration (2027-2032) & (M Doses)
Table 57. World Newcastle Disease Vaccine Production Value by Administration (2021-2026) & (USD Million)
Table 58. World Newcastle Disease Vaccine Production Value by Administration (2027-2032) & (USD Million)
Table 59. World Newcastle Disease Vaccine Average Price by Administration (2021-2026) & (USD/K Doses)
Table 60. World Newcastle Disease Vaccine Average Price by Administration (2027-2032) & (USD/K Doses)
Table 61. World Newcastle Disease Vaccine Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 62. World Newcastle Disease Vaccine Production by End User (2021-2026) & (M Doses)
Table 63. World Newcastle Disease Vaccine Production by End User (2027-2032) & (M Doses)
Table 64. World Newcastle Disease Vaccine Production Value by End User (2021-2026) & (USD Million)
Table 65. World Newcastle Disease Vaccine Production Value by End User (2027-2032) & (USD Million)
Table 66. World Newcastle Disease Vaccine Average Price by End User (2021-2026) & (USD/K Doses)
Table 67. World Newcastle Disease Vaccine Average Price by End User (2027-2032) & (USD/K Doses)
Table 68. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Newcastle Disease Vaccine Production by Application (2021-2026) & (M Doses)
Table 70. World Newcastle Disease Vaccine Production by Application (2027-2032) & (M Doses)
Table 71. World Newcastle Disease Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Newcastle Disease Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Newcastle Disease Vaccine Average Price by Application (2021-2026) & (USD/K Doses)
Table 74. World Newcastle Disease Vaccine Average Price by Application (2027-2032) & (USD/K Doses)
Table 75. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
Table 78. Boehringer Ingelheim Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 81. CEVA Basic Information, Manufacturing Base and Competitors
Table 82. CEVA Major Business
Table 83. CEVA Newcastle Disease Vaccine Product and Services
Table 84. CEVA Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. CEVA Recent Developments/Updates
Table 86. CEVA Competitive Strengths & Weaknesses
Table 87. CAHIC Basic Information, Manufacturing Base and Competitors
Table 88. CAHIC Major Business
Table 89. CAHIC Newcastle Disease Vaccine Product and Services
Table 90. CAHIC Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. CAHIC Recent Developments/Updates
Table 92. CAHIC Competitive Strengths & Weaknesses
Table 93. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 94. Ringpu Biology Major Business
Table 95. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 96. Ringpu Biology Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Ringpu Biology Recent Developments/Updates
Table 98. Ringpu Biology Competitive Strengths & Weaknesses
Table 99. Yebio Basic Information, Manufacturing Base and Competitors
Table 100. Yebio Major Business
Table 101. Yebio Newcastle Disease Vaccine Product and Services
Table 102. Yebio Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Yebio Recent Developments/Updates
Table 104. Yebio Competitive Strengths & Weaknesses
Table 105. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 106. Harbin Veterinary Research Institute Major Business
Table 107. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 108. Harbin Veterinary Research Institute Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Harbin Veterinary Research Institute Recent Developments/Updates
Table 110. Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
Table 111. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 112. Merck Animal Health Major Business
Table 113. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 114. Merck Animal Health Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Merck Animal Health Recent Developments/Updates
Table 116. Merck Animal Health Competitive Strengths & Weaknesses
Table 117. DHN Basic Information, Manufacturing Base and Competitors
Table 118. DHN Major Business
Table 119. DHN Newcastle Disease Vaccine Product and Services
Table 120. DHN Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. DHN Recent Developments/Updates
Table 122. DHN Competitive Strengths & Weaknesses
Table 123. Zoetis Basic Information, Manufacturing Base and Competitors
Table 124. Zoetis Major Business
Table 125. Zoetis Newcastle Disease Vaccine Product and Services
Table 126. Zoetis Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Zoetis Recent Developments/Updates
Table 128. Zoetis Competitive Strengths & Weaknesses
Table 129. Elanco Basic Information, Manufacturing Base and Competitors
Table 130. Elanco Major Business
Table 131. Elanco Newcastle Disease Vaccine Product and Services
Table 132. Elanco Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Elanco Recent Developments/Updates
Table 134. Elanco Competitive Strengths & Weaknesses
Table 135. FATRO Basic Information, Manufacturing Base and Competitors
Table 136. FATRO Major Business
Table 137. FATRO Newcastle Disease Vaccine Product and Services
Table 138. FATRO Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. FATRO Recent Developments/Updates
Table 140. FATRO Competitive Strengths & Weaknesses
Table 141. CAVAC Basic Information, Manufacturing Base and Competitors
Table 142. CAVAC Major Business
Table 143. CAVAC Newcastle Disease Vaccine Product and Services
Table 144. CAVAC Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. CAVAC Recent Developments/Updates
Table 146. CAVAC Competitive Strengths & Weaknesses
Table 147. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 148. Vaksindo Major Business
Table 149. Vaksindo Newcastle Disease Vaccine Product and Services
Table 150. Vaksindo Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Vaksindo Recent Developments/Updates
Table 152. Vaksindo Competitive Strengths & Weaknesses
Table 153. Virbac Basic Information, Manufacturing Base and Competitors
Table 154. Virbac Major Business
Table 155. Virbac Newcastle Disease Vaccine Product and Services
Table 156. Virbac Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Virbac Recent Developments/Updates
Table 158. Virbac Competitive Strengths & Weaknesses
Table 159. Hester Biosciences Basic Information, Manufacturing Base and Competitors
Table 160. Hester Biosciences Major Business
Table 161. Hester Biosciences Newcastle Disease Vaccine Product and Services
Table 162. Hester Biosciences Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Hester Biosciences Recent Developments/Updates
Table 164. Hester Biosciences Competitive Strengths & Weaknesses
Table 165. Global Key Players of Newcastle Disease Vaccine Upstream (Raw Materials)
Table 166. Global Newcastle Disease Vaccine Typical Customers
Table 167. Newcastle Disease Vaccine Typical Distributors
Table 1. World Newcastle Disease Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Newcastle Disease Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Newcastle Disease Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Newcastle Disease Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Newcastle Disease Vaccine Production by Region (2021-2026) & (M Doses)
Table 7. World Newcastle Disease Vaccine Production by Region (2027-2032) & (M Doses)
Table 8. World Newcastle Disease Vaccine Production Market Share by Region (2021-2026)
Table 9. World Newcastle Disease Vaccine Production Market Share by Region (2027-2032)
Table 10. World Newcastle Disease Vaccine Average Price by Region (2021-2026) & (USD/K Doses)
Table 11. World Newcastle Disease Vaccine Average Price by Region (2027-2032) & (USD/K Doses)
Table 12. Newcastle Disease Vaccine Major Market Trends
Table 13. World Newcastle Disease Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Doses)
Table 14. World Newcastle Disease Vaccine Consumption by Region (2021-2026) & (M Doses)
Table 15. World Newcastle Disease Vaccine Consumption Forecast by Region (2027-2032) & (M Doses)
Table 16. World Newcastle Disease Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 18. World Newcastle Disease Vaccine Production by Manufacturer (2021-2026) & (M Doses)
Table 19. Production Market Share of Key Newcastle Disease Vaccine Producers in 2025
Table 20. World Newcastle Disease Vaccine Average Price by Manufacturer (2021-2026) & (USD/K Doses)
Table 21. Global Newcastle Disease Vaccine Company Evaluation Quadrant
Table 22. World Newcastle Disease Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Newcastle Disease Vaccine Production Site of Key Manufacturer
Table 24. Newcastle Disease Vaccine Market: Company Product Type Footprint
Table 25. Newcastle Disease Vaccine Market: Company Product Application Footprint
Table 26. Newcastle Disease Vaccine Competitive Factors
Table 27. Newcastle Disease Vaccine New Entrant and Capacity Expansion Plans
Table 28. Newcastle Disease Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Newcastle Disease Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Newcastle Disease Vaccine Production Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 31. United States VS China Newcastle Disease Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 32. United States Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Newcastle Disease Vaccine Production (2021-2026) & (M Doses)
Table 36. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 37. China Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 41. China Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Newcastle Disease Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Newcastle Disease Vaccine Production, (2021-2026) & (M Doses)
Table 46. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share (2021-2026)
Table 47. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Newcastle Disease Vaccine Production by Type (2021-2026) & (M Doses)
Table 49. World Newcastle Disease Vaccine Production by Type (2027-2032) & (M Doses)
Table 50. World Newcastle Disease Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Newcastle Disease Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Newcastle Disease Vaccine Average Price by Type (2021-2026) & (USD/K Doses)
Table 53. World Newcastle Disease Vaccine Average Price by Type (2027-2032) & (USD/K Doses)
Table 54. World Newcastle Disease Vaccine Production Value by Administration, (USD Million), 2021 & 2025 & 2032
Table 55. World Newcastle Disease Vaccine Production by Administration (2021-2026) & (M Doses)
Table 56. World Newcastle Disease Vaccine Production by Administration (2027-2032) & (M Doses)
Table 57. World Newcastle Disease Vaccine Production Value by Administration (2021-2026) & (USD Million)
Table 58. World Newcastle Disease Vaccine Production Value by Administration (2027-2032) & (USD Million)
Table 59. World Newcastle Disease Vaccine Average Price by Administration (2021-2026) & (USD/K Doses)
Table 60. World Newcastle Disease Vaccine Average Price by Administration (2027-2032) & (USD/K Doses)
Table 61. World Newcastle Disease Vaccine Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 62. World Newcastle Disease Vaccine Production by End User (2021-2026) & (M Doses)
Table 63. World Newcastle Disease Vaccine Production by End User (2027-2032) & (M Doses)
Table 64. World Newcastle Disease Vaccine Production Value by End User (2021-2026) & (USD Million)
Table 65. World Newcastle Disease Vaccine Production Value by End User (2027-2032) & (USD Million)
Table 66. World Newcastle Disease Vaccine Average Price by End User (2021-2026) & (USD/K Doses)
Table 67. World Newcastle Disease Vaccine Average Price by End User (2027-2032) & (USD/K Doses)
Table 68. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Newcastle Disease Vaccine Production by Application (2021-2026) & (M Doses)
Table 70. World Newcastle Disease Vaccine Production by Application (2027-2032) & (M Doses)
Table 71. World Newcastle Disease Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Newcastle Disease Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Newcastle Disease Vaccine Average Price by Application (2021-2026) & (USD/K Doses)
Table 74. World Newcastle Disease Vaccine Average Price by Application (2027-2032) & (USD/K Doses)
Table 75. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 76. Boehringer Ingelheim Major Business
Table 77. Boehringer Ingelheim Newcastle Disease Vaccine Product and Services
Table 78. Boehringer Ingelheim Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 81. CEVA Basic Information, Manufacturing Base and Competitors
Table 82. CEVA Major Business
Table 83. CEVA Newcastle Disease Vaccine Product and Services
Table 84. CEVA Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. CEVA Recent Developments/Updates
Table 86. CEVA Competitive Strengths & Weaknesses
Table 87. CAHIC Basic Information, Manufacturing Base and Competitors
Table 88. CAHIC Major Business
Table 89. CAHIC Newcastle Disease Vaccine Product and Services
Table 90. CAHIC Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. CAHIC Recent Developments/Updates
Table 92. CAHIC Competitive Strengths & Weaknesses
Table 93. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 94. Ringpu Biology Major Business
Table 95. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 96. Ringpu Biology Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Ringpu Biology Recent Developments/Updates
Table 98. Ringpu Biology Competitive Strengths & Weaknesses
Table 99. Yebio Basic Information, Manufacturing Base and Competitors
Table 100. Yebio Major Business
Table 101. Yebio Newcastle Disease Vaccine Product and Services
Table 102. Yebio Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Yebio Recent Developments/Updates
Table 104. Yebio Competitive Strengths & Weaknesses
Table 105. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 106. Harbin Veterinary Research Institute Major Business
Table 107. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 108. Harbin Veterinary Research Institute Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Harbin Veterinary Research Institute Recent Developments/Updates
Table 110. Harbin Veterinary Research Institute Competitive Strengths & Weaknesses
Table 111. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 112. Merck Animal Health Major Business
Table 113. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 114. Merck Animal Health Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Merck Animal Health Recent Developments/Updates
Table 116. Merck Animal Health Competitive Strengths & Weaknesses
Table 117. DHN Basic Information, Manufacturing Base and Competitors
Table 118. DHN Major Business
Table 119. DHN Newcastle Disease Vaccine Product and Services
Table 120. DHN Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. DHN Recent Developments/Updates
Table 122. DHN Competitive Strengths & Weaknesses
Table 123. Zoetis Basic Information, Manufacturing Base and Competitors
Table 124. Zoetis Major Business
Table 125. Zoetis Newcastle Disease Vaccine Product and Services
Table 126. Zoetis Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Zoetis Recent Developments/Updates
Table 128. Zoetis Competitive Strengths & Weaknesses
Table 129. Elanco Basic Information, Manufacturing Base and Competitors
Table 130. Elanco Major Business
Table 131. Elanco Newcastle Disease Vaccine Product and Services
Table 132. Elanco Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Elanco Recent Developments/Updates
Table 134. Elanco Competitive Strengths & Weaknesses
Table 135. FATRO Basic Information, Manufacturing Base and Competitors
Table 136. FATRO Major Business
Table 137. FATRO Newcastle Disease Vaccine Product and Services
Table 138. FATRO Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. FATRO Recent Developments/Updates
Table 140. FATRO Competitive Strengths & Weaknesses
Table 141. CAVAC Basic Information, Manufacturing Base and Competitors
Table 142. CAVAC Major Business
Table 143. CAVAC Newcastle Disease Vaccine Product and Services
Table 144. CAVAC Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. CAVAC Recent Developments/Updates
Table 146. CAVAC Competitive Strengths & Weaknesses
Table 147. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 148. Vaksindo Major Business
Table 149. Vaksindo Newcastle Disease Vaccine Product and Services
Table 150. Vaksindo Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Vaksindo Recent Developments/Updates
Table 152. Vaksindo Competitive Strengths & Weaknesses
Table 153. Virbac Basic Information, Manufacturing Base and Competitors
Table 154. Virbac Major Business
Table 155. Virbac Newcastle Disease Vaccine Product and Services
Table 156. Virbac Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Virbac Recent Developments/Updates
Table 158. Virbac Competitive Strengths & Weaknesses
Table 159. Hester Biosciences Basic Information, Manufacturing Base and Competitors
Table 160. Hester Biosciences Major Business
Table 161. Hester Biosciences Newcastle Disease Vaccine Product and Services
Table 162. Hester Biosciences Newcastle Disease Vaccine Production (M Doses), Price (USD/K Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Hester Biosciences Recent Developments/Updates
Table 164. Hester Biosciences Competitive Strengths & Weaknesses
Table 165. Global Key Players of Newcastle Disease Vaccine Upstream (Raw Materials)
Table 166. Global Newcastle Disease Vaccine Typical Customers
Table 167. Newcastle Disease Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. World Newcastle Disease Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Newcastle Disease Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 5. World Newcastle Disease Vaccine Average Price (2021-2032) & (USD/K Doses)
Figure 6. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Newcastle Disease Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 9. Europe Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 10. Southeast Asia Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 11. Japan Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 12. China Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 13. South Korea Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 14. Newcastle Disease Vaccine Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 17. World Newcastle Disease Vaccine Consumption Market Share by Region (2021-2032)
Figure 18. United States Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 19. China Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 20. Europe Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 21. Japan Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 22. South Korea Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 23. ASEAN Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 24. India Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 25. Producer Shipments of Newcastle Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Newcastle Disease Vaccine Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Newcastle Disease Vaccine Markets in 2025
Figure 28. United States VS China: Newcastle Disease Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Newcastle Disease Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Newcastle Disease Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 32. China Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 34. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Newcastle Disease Vaccine Production Value Market Share by Type in 2025
Figure 36. Live Vaccines
Figure 37. Killed Vaccines
Figure 38. World Newcastle Disease Vaccine Production Market Share by Type (2021-2032)
Figure 39. World Newcastle Disease Vaccine Production Value Market Share by Type (2021-2032)
Figure 40. World Newcastle Disease Vaccine Average Price by Type (2021-2032) & (USD/K Doses)
Figure 41. World Newcastle Disease Vaccine Production Value by Administration, (USD Million), 2021 & 2025 & 2032
Figure 42. World Newcastle Disease Vaccine Production Value Market Share by Administration in 2025
Figure 43. Spray Method
Figure 44. Drinking Water
Figure 45. Injection Method
Figure 46. World Newcastle Disease Vaccine Production Market Share by Administration (2021-2032)
Figure 47. World Newcastle Disease Vaccine Production Value Market Share by Administration (2021-2032)
Figure 48. World Newcastle Disease Vaccine Average Price by Administration (2021-2032) & (USD/K Doses)
Figure 49. World Newcastle Disease Vaccine Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 50. World Newcastle Disease Vaccine Production Value Market Share by End User in 2025
Figure 51. Large Farms
Figure 52. Small Farms
Figure 53. Government Use
Figure 54. World Newcastle Disease Vaccine Production Market Share by End User (2021-2032)
Figure 55. World Newcastle Disease Vaccine Production Value Market Share by End User (2021-2032)
Figure 56. World Newcastle Disease Vaccine Average Price by End User (2021-2032) & (USD/K Doses)
Figure 57. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Newcastle Disease Vaccine Production Value Market Share by Application in 2025
Figure 59. Chicken
Figure 60. Duck & Goose
Figure 61. Other
Figure 62. World Newcastle Disease Vaccine Production Market Share by Application (2021-2032)
Figure 63. World Newcastle Disease Vaccine Production Value Market Share by Application (2021-2032)
Figure 64. World Newcastle Disease Vaccine Average Price by Application (2021-2032) & (USD/K Doses)
Figure 65. Newcastle Disease Vaccine Industry Chain
Figure 66. Newcastle Disease Vaccine Procurement Model
Figure 67. Newcastle Disease Vaccine Sales Model
Figure 68. Newcastle Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. World Newcastle Disease Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Newcastle Disease Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 5. World Newcastle Disease Vaccine Average Price (2021-2032) & (USD/K Doses)
Figure 6. World Newcastle Disease Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Newcastle Disease Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 9. Europe Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 10. Southeast Asia Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 11. Japan Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 12. China Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 13. South Korea Newcastle Disease Vaccine Production (2021-2032) & (M Doses)
Figure 14. Newcastle Disease Vaccine Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 17. World Newcastle Disease Vaccine Consumption Market Share by Region (2021-2032)
Figure 18. United States Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 19. China Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 20. Europe Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 21. Japan Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 22. South Korea Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 23. ASEAN Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 24. India Newcastle Disease Vaccine Consumption (2021-2032) & (M Doses)
Figure 25. Producer Shipments of Newcastle Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Newcastle Disease Vaccine Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Newcastle Disease Vaccine Markets in 2025
Figure 28. United States VS China: Newcastle Disease Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Newcastle Disease Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Newcastle Disease Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 32. China Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Newcastle Disease Vaccine Production Market Share 2025
Figure 34. World Newcastle Disease Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Newcastle Disease Vaccine Production Value Market Share by Type in 2025
Figure 36. Live Vaccines
Figure 37. Killed Vaccines
Figure 38. World Newcastle Disease Vaccine Production Market Share by Type (2021-2032)
Figure 39. World Newcastle Disease Vaccine Production Value Market Share by Type (2021-2032)
Figure 40. World Newcastle Disease Vaccine Average Price by Type (2021-2032) & (USD/K Doses)
Figure 41. World Newcastle Disease Vaccine Production Value by Administration, (USD Million), 2021 & 2025 & 2032
Figure 42. World Newcastle Disease Vaccine Production Value Market Share by Administration in 2025
Figure 43. Spray Method
Figure 44. Drinking Water
Figure 45. Injection Method
Figure 46. World Newcastle Disease Vaccine Production Market Share by Administration (2021-2032)
Figure 47. World Newcastle Disease Vaccine Production Value Market Share by Administration (2021-2032)
Figure 48. World Newcastle Disease Vaccine Average Price by Administration (2021-2032) & (USD/K Doses)
Figure 49. World Newcastle Disease Vaccine Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 50. World Newcastle Disease Vaccine Production Value Market Share by End User in 2025
Figure 51. Large Farms
Figure 52. Small Farms
Figure 53. Government Use
Figure 54. World Newcastle Disease Vaccine Production Market Share by End User (2021-2032)
Figure 55. World Newcastle Disease Vaccine Production Value Market Share by End User (2021-2032)
Figure 56. World Newcastle Disease Vaccine Average Price by End User (2021-2032) & (USD/K Doses)
Figure 57. World Newcastle Disease Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Newcastle Disease Vaccine Production Value Market Share by Application in 2025
Figure 59. Chicken
Figure 60. Duck & Goose
Figure 61. Other
Figure 62. World Newcastle Disease Vaccine Production Market Share by Application (2021-2032)
Figure 63. World Newcastle Disease Vaccine Production Value Market Share by Application (2021-2032)
Figure 64. World Newcastle Disease Vaccine Average Price by Application (2021-2032) & (USD/K Doses)
Figure 65. Newcastle Disease Vaccine Industry Chain
Figure 66. Newcastle Disease Vaccine Procurement Model
Figure 67. Newcastle Disease Vaccine Sales Model
Figure 68. Newcastle Disease Vaccine Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source
